ArticleVaccines2022

Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19.

Dong-In Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.